Dec 16 2009
Potential acquisition will expand product portfolio and Introduces Medical
Devices to BioStar's Distribution Network
Biostar
Pharmaceuticals, Inc. (OTC Bulletin Board: BSPM) ("Biostar" or "the Company"),
a Xianyang-based developer, manufacturer and supplier of pharmaceutical
products and medical nutrients addressing a variety of diseases and conditions,
today announced it has signed a letter of intent ("LOI') with a Xi'an-based
medical equipment and nutrients manufacturer ("Acquiree") to acquire 100% of
the Acquiree for $1.1 million in cash.
The Acquiree manufactures and distributes topical hernia treatment belts
with two traditional Chinese medicine bags being applied to body points
associated with hernia. The Acquiree also manufactures a nutraceutical product
for treatment of gynecological inflammation in young and middle-aged women.
The Acquiree has been manufacturing and selling its products in Xi'an and an
adjacent province since 2004. Biostar has calculated the revenue contribution
from the acquisition to add approximately $3.0 million in revenues to
BioStar's revenues in 2010.
"Our potential acquisition of this company will add a unique medical
device and other nutrients to our portfolio of medicines as well as open a
medical equipment distribution opportunity for us," began Mr. Rongua Wang,
Chairman and CEO of Biostar Pharmaceuticals. "We have been monitoring this
target acquisition for the last couple of years and have always been impressed
with the market potential of its product line. If the acquisition is
successful, we anticipate a very smooth assimilation of their products into
our distribution network and corporate culture," Mr. Wang concluded.
SOURCE Biostar Pharmaceuticals, Inc.